Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development program.

Carel W le Roux,Shuyu Zhang,Louis J Aronne,Robert F Kushner,Ariana M Chao,Sriram Machineni,Julia Dunn, Farai B Chigutsa,Nadia N Ahmad,Mathijs C Bunck

Obesity (Silver Spring, Md.)（2023）

Cited 10|Views20
No score
Abstract
The extensive assessment of once-weekly tirzepatide in the global SURMOUNT program will detail the clinical effects of this first-in-class glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist in chronic weight management.
More
Translated text
Key words
obesity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined